Author: Elizabeth Gregerson

Physicians are divided over two prostate cancer treatment protocols: the watch-and-wait approach and surgery.

In partnership with Microsoft, biotechnology company Paige has created the largest AI model for cancer diagnosis to date.

Hackensack Meridian Health's John Theurer Cancer Center in Hackensack, N.J., has launched a cancer risk assessment initiative, the goal of which is to improve access to screening and facilitate earlier detection. 

Leaders from two of the top five cancer centers, as ranked by U.S. News & World Report, shared with Becker's the best leadership advice they have received.

Imfinzi, a drug manufactured by AstraZeneca, has been approved by the FDA for treatment of early-stage, non-small cell lung cancer in combination with chemotherapy.

Wakefield, R.I.-based South County Health experienced a staffing shake-up this summer after three hematology oncology providers resigned due to "chronic underfunding."

Patient-reported outcome measures improve survival risk and quality of life for cancer patients, according to a study published Aug. 13 in JAMA Network Open. 

The Biden administration will dole out up to $150 million in research funding awards as part of its Cancer Moonshot initiative.

Global cancer deaths among men are projected to increase more than 93% from 5.4 million in 2022 to 10.5 million in 2050, according to a study published Aug. 12 in the American Cancer Society journal Cancer.

When Eileen Hacker, PhD, APRN, was overcome with emotion upon being inducted into the International Nurse Researcher Hall of Fame. When reached by Becker's, she called it an honor and a privilege.